Bearz A - Search Results

1

Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer.

Bearz A, Cecco S, Francescon S, Re FL, Corona G, Baldo P. Bearz A, et al. Recent Pat Anticancer Drug Discov. 2019;14(3):242-257. doi: 10.2174/1574892814666190726124735. Recent Pat Anticancer Drug Discov. 2019. PMID: 31362665 Review.

2

Pharmacology of chronic oral daily administration of idarubicin.

Toffoli G, Sorio R, Aita P, Crivellari D, Corona G, Rimondi G, Bearz A, Stocco F, Robieux I, Boiocchi M. Toffoli G, et al. Among authors: bearz a. Haematologica. 1997 Sep-Oct;82(5 Suppl):1-3. Haematologica. 1997. PMID: 9402745 Clinical Trial.

3

Pharmacokinetic interaction between etoposide and tamoxifen in patients with hepatocellular carcinoma.

Corona G, Aita P, Sorio R, Colussi AM, Bearz A, Sartor F, Boiocchi M, Toffoli G. Corona G, et al. Among authors: bearz a. Anticancer Drugs. 1999 Oct;10(9):815-9. doi: 10.1097/00001813-199910000-00004. Anticancer Drugs. 1999. PMID: 10587291 Clinical Trial.

4

Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patients.

Toffoli G, Sorio R, Aita P, Crivellari D, Corona G, Bearz A, Robieux I, Colussi AM, Stocco F, Boiocchi M. Toffoli G, et al. Among authors: bearz a. Clin Cancer Res. 2000 Jun;6(6):2279-87. Clin Cancer Res. 2000. PMID: 10873078 Clinical Trial.

5

Oral etoposide in elderly patients with advanced non small cell lung cancer: a clinical and pharmacological study.

Sorio R, Toffoli G, Crivellari D, Bearz A, Corona G, Colussi AM, Libra M, Talamini R, Veronesi A. Sorio R, et al. Among authors: bearz a. J Chemother. 2006 Apr;18(2):188-91. doi: 10.1179/joc.2006.18.2.188. J Chemother. 2006. PMID: 16736888 Clinical Trial.

6

Interferon-alpha for maintenance of follicular lymphoma.

Baldo P, Rupolo M, Compagnoni A, Lazzarini R, Bearz A, Cannizzaro R, Spazzapan S, Truccolo I, Moja L. Baldo P, et al. Among authors: bearz a. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD004629. doi: 10.1002/14651858.CD004629.pub2. Cochrane Database Syst Rev. 2010. PMID: 20091564 Review.

7

Target therapies in lung cancer.

Bearz A, Berretta M, Lleshi A, Tirelli U. Bearz A, et al. J Biomed Biotechnol. 2011;2011:921231. doi: 10.1155/2011/921231. Epub 2011 Mar 30. J Biomed Biotechnol. 2011. PMID: 21541198 Free PMC article. Review.

8

First-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer : analysis of the Italian patients enrolled in the SAiL study.

Bearz A, Passalacqua R, Alabiso O, Cinieri S, Gridelli C, Cravesana C, Crinò L. Bearz A, et al. Clin Drug Investig. 2012 Nov;32(11):755-60. doi: 10.1007/s40261-012-0001-9. Clin Drug Investig. 2012. PMID: 23018280 Clinical Trial.

9

Treatment of elderly patients affected by lung cancer: why to treat, when to treat and what we know.

Bearz A, Berretta M, Lleshi A, Berto E, Tirelli U. Bearz A, et al. Anticancer Agents Med Chem. 2013 Nov;13(9):1378-82. doi: 10.2174/18715206113136660353. Anticancer Agents Med Chem. 2013. PMID: 24102274 Review.

10

Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patients.

Berretta M, Aprile G, Nasti G, Urbani M, Bearz A, Lutrino S, Foltran L, Ferrari L, Talamini R, Fiorica F, Lleshi A, Canzonieri V, Lestuzzi C, Borsatti E, Fisichella R, Tirelli U. Berretta M, et al. Among authors: bearz a. Anticancer Agents Med Chem. 2013 Nov;13(9):1344-53. doi: 10.2174/18715206113136660347. Anticancer Agents Med Chem. 2013. PMID: 24102280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page